Secrets St. Martin all-inclusive
Date/Time
Date(s) - November 12,2021 - November 14,2021
8:00 am - 1:00 pm
Category(ies)
HOTEL INFO: Please call us to assist with your room reservation
Secrets St. Martin (adult only resort)
Mandatory to stay at this resort if attending seminars
www.secretsresorts.com
Dr. Stan Louie, Pharm D.
University of Southern California
Dr. Stan Louie received his Doctorate in Pharmacy from the University of California in San Francisco. He continued his postgraduate work at Pacific Presbyterian Medical Center in San Francisco where he was a pharmacy resident. In addition to clinical training, he continued his basic science training at the Kuzell Institute, where he served as Associate of Research in Molecular Biology. Following his training at Kuzell, he joined USC where he continued his work on cytokine regulation in relation to tumor and/or viral proliferation at the Kenneth Norris Cancer Research Institute. Presently, he is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include HIV and hepatitis B & C. In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.
Friday November 12, 2021
ADVANCES IN ANTIVIRAL THERAPY
ACPE# TBA
Objectives:
TBA
_________________________________________________________________________________
Saturday November 13, 2021
UPDATES ON THE TREATMENT OF AUTOIMMUNE DISEASE
ACPE# TBA
Objectives:
- Describe contributive factors to autoimmune diseases.
- Distinguish between organ specific and systemic autoimmune diseases with examples of each.
- Explain immunologic mechanism known to cause destruction of cells found in the CNS.
- Describe the effects of multiple sclerosis on the targeted organs.
- Relate genetic susceptibility to the development of MS.
Sunday November 14, 2021
THE PHARMACIST ROLE IN BIOTERRORISM
ACPE # TBA
Objectives:
1. Recognize the mechanism of injury induced by radiation.
2. Determine the window of opportunity for radiation-induced injuries (e.g. GI, hematologic, and cutaneous injuries).
3. Be able to manage the efficacy and adverse effects associated with new mitigation agents.
4. Recognize the different clinical manifestations of various infectious agents (e.g. bacteria, viruses and biotoxins).
5. Develop pharmaceutical care strategies to reduce the adverse events of both the injuries and drug therapy.